Clinical Outcomes of the Use of a Femtosecond Laser on an Implanted Intraocular Lens

Exclusion Criteria

• •1. Subject not able to complete the informed consent form.
• •2. Astigmatism greater than 3 diopter.
• •3. Spherical diopter error of greater than 4 diopters.
• •4. Combined spherical and cylinder diopter error of greater than 5 diopters.
• •5. Clinically significant corneal abnormalities including corneal dystrophy (e.g. epithelial, stromal, or endothelial dystrophy), inflammation, keratitis, keratoconjunctivitis, keratouveitis, keratopathy, keratectasia or edema per the Investigator's expert medical opinion.
• •6. Previous corneal transplant.
• •7. Previous refractive surgery or proposed refractive surgery procedures throughout the entire duration of the subject's participation in the clinical study (including, but not limited to LASIK, astigmatic keratotomy and limbal relaxing incisions).
• •8. History of or current retinal conditions or predisposition to retinal conditions, previous history of, or a predisposition to, retinal detachment or presence of diabetic retinopathy that the Investigator judges could confound outcomes, including but not limited to background diabetic retinopathy, diabetic macular edema or proliferative diabetic retinopathy, macular degeneration.
• •9. Amblyopia.
• •10. History of or current anterior or posterior segment inflammation of any etiology, or any disease producing an inflammatory reaction in the eye (e.g. iritis or uveitis).
• •11. Glaucoma.
• •12. Optic nerve atrophy.
• •13. Iris neovascularization.
• •14. Subjects with diagnosed degenerative eye disorders (e.g. macular degeneration or other retinal disorders).
• •15. Any subject currently participating in another investigational drug or device study.